DHEA (DEHYDROEPIANDROSTERONE)

DHEA (DEHYDROEPIANDROSTERONE) was reported 1907 times

DHEA (DEHYDROEPIANDROSTERONE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN ANORECTAL NEOPLASM 1 0.0455
1 ADMINISTRATION SITE SCAB 1 0.0385
2 TRAUMATIC ARTHRITIS 2 0.0364
3 DEHYDROEPIANDROSTERONE INCREASED 2 0.0290
4 PROGESTERONE INCREASED 3 0.0270
5 ARTHROPOD INFESTATION 2 0.0270
6 FEMALE SEXUAL AROUSAL DISORDER 2 0.0217
7 DEHYDROEPIANDROSTERONE DECREASED 2 0.0202
8 ANDROPAUSE 1 0.0192
9 ADMINISTRATION SITE SCAR 1 0.0161
10 BLOOD TESTOSTERONE FREE DECREASED 2 0.0153
11 BLOOD CORTISOL INCREASED 4 0.0151
12 CARDIAC PERFORATION 3 0.0130
13 LENTIGO MALIGNA 3 0.0112
14 BRACHIAL PLEXOPATHY 2 0.0090
15 BLADDER NECK SUSPENSION 1 0.0089
16 VAGINAL MYCOSIS 2 0.0086
17 BLOOD CATECHOLAMINES INCREASED 1 0.0080
18 AUTOIMMUNE NEUROPATHY 1 0.0078
19 AUTOMATIC BLADDER 1 0.0072
20 VERTEBRAL OSTEOPHYTE 3 0.0070
21 OESTRADIOL INCREASED 2 0.0066
22 ANAL DISCOMFORT 1 0.0065
23 OESOPHAGEAL MOTILITY DISORDER 2 0.0056
24 FIBROCYSTIC BREAST DISEASE 4 0.0054
25 ADRENOCORTICAL INSUFFICIENCY ACUTE 10 0.0051
26 ASPIRATION JOINT 1 0.0050
27 ELECTROMECHANICAL DISSOCIATION 4 0.0050
28 BENIGN HEPATIC NEOPLASM 1 0.0050
29 PRE-EXISTING CONDITION IMPROVED 30 0.0048
30 ANEMBRYONIC GESTATION 1 0.0048
31 CAROTID ARTERY DISSECTION 2 0.0047
32 HAEMANGIOMA OF SKIN 2 0.0046
33 BLADDER HYPERTROPHY 2 0.0045
34 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
35 APPLICATION SITE HYPOAESTHESIA 1 0.0043
36 ANORECTAL OPERATION 1 0.0042
37 BIOPSY SKIN ABNORMAL 1 0.0042
38 BLOOD BICARBONATE INCREASED 2 0.0042
39 EXPOSURE TO COMMUNICABLE DISEASE 3 0.0040
40 INSULIN-LIKE GROWTH FACTOR DECREASED 2 0.0038
41 POST-TRAUMATIC NECK SYNDROME 3 0.0037
42 APPLICATION SITE MASS 1 0.0036
43 SLEEP WALKING 2 0.0035
44 PREMATURE MENOPAUSE 3 0.0032
45 SPIDER VEIN 2 0.0031
46 THYROXINE FREE INCREASED 2 0.0031
47 BLOOD CORTISOL DECREASED 2 0.0031
48 PHAEOCHROMOCYTOMA 2 0.0030
49 LYME DISEASE 10 0.0030
50 BLOOD OESTROGEN DECREASED 2 0.0028
51 MULTIPLE DRUG THERAPY 2 0.0027
52 LUMBAR RADICULOPATHY 3 0.0026
53 BRONCHIAL HYPERREACTIVITY 3 0.0025
54 AMMONIA ABNORMAL 1 0.0025
55 VULVOVAGINAL ERYTHEMA 2 0.0024
56 BLOOD TESTOSTERONE INCREASED 5 0.0023
57 EFFUSION 3 0.0022
58 ISCHAEMIC HEPATITIS 3 0.0022
59 CATAPLEXY 3 0.0021
60 SNORING 8 0.0021
61 INSULIN-LIKE GROWTH FACTOR INCREASED 3 0.0021
62 PROSTATE INFECTION 2 0.0021
63 TESTICULAR DISORDER 2 0.0020
64 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
65 JOINT SPRAIN 2 0.0019
66 BLOOD TESTOSTERONE DECREASED 13 0.0019
67 STRESS URINARY INCONTINENCE 2 0.0019
68 PERICARDIAL HAEMORRHAGE 4 0.0018
69 MUSCLE RUPTURE 7 0.0018
70 ADMINISTRATION SITE PAIN 2 0.0017
71 SENSITIVITY OF TEETH 3 0.0017
72 SPONDYLOLISTHESIS 3 0.0017
73 ROTATOR CUFF REPAIR 3 0.0017
74 ADENOMYOSIS 1 0.0017
75 VULVOVAGINAL SWELLING 3 0.0016
76 OTITIS EXTERNA 2 0.0016
77 MALIGNANT MELANOMA IN SITU 2 0.0016
78 FRACTURED SACRUM 2 0.0016
79 SEROMA 2 0.0016
80 ENDOCRINE DISORDER 2 0.0016
81 OVARIAN CYST RUPTURED 2 0.0016
82 APPLICATION SITE EROSION 2 0.0016
83 DACRYOSTENOSIS ACQUIRED 2 0.0015
84 GASTROENTERITIS NOROVIRUS 2 0.0015
85 ENURESIS 6 0.0015
86 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
87 EOSINOPHILIC OESOPHAGITIS 4 0.0014
88 CHRONIC FATIGUE SYNDROME 2 0.0014
89 HORMONE LEVEL ABNORMAL 7 0.0014
90 SLEEP APNOEA SYNDROME 27 0.0014
91 SMEAR CERVIX ABNORMAL 2 0.0014
92 TENSION HEADACHE 6 0.0014
93 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
94 SUPERINFECTION 2 0.0013
95 ORAL MUCOSAL ERUPTION 2 0.0013
96 URINARY HESITATION 3 0.0013
97 NASAL ULCER 2 0.0013
98 BARRETT'S OESOPHAGUS 1 0.0012
99 PITUITARY TUMOUR BENIGN 2 0.0012
100 ENTERITIS INFECTIOUS 2 0.0012
101 RECALLED PRODUCT 2 0.0012
102 ARTERIAL STENOSIS 1 0.0011
103 LYMPH NODE PAIN 2 0.0011
104 NARCOLEPSY 2 0.0011
105 ARNOLD-CHIARI MALFORMATION 1 0.0010
106 GINGIVAL RECESSION 2 0.0010
107 APPLICATION SITE BRUISE 1 0.0010
108 LUMBAR SPINAL STENOSIS 3 0.0010
109 HYPOGEUSIA 2 0.0010
110 EMPYEMA 2 0.0010
111 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
112 ANTISOCIAL BEHAVIOUR 1 0.0010
113 CORONARY ARTERY THROMBOSIS 2 0.0010
114 VULVOVAGINAL BURNING SENSATION 6 0.0010
115 NIPPLE PAIN 2 0.0010
116 THYROID DISORDER 15 0.0010
117 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
118 INFUSION SITE SWELLING 6 0.0010
119 DEVICE MATERIAL ISSUE 2 0.0010
120 INFUSION SITE PRURITUS 3 0.0009
121 NON-CARDIAC CHEST PAIN 3 0.0009
122 NEUROGENIC BLADDER 2 0.0009
123 APPLICATION SITE PAPULES 1 0.0009
124 ALLERGY TO ANIMAL 1 0.0009
125 SHOULDER OPERATION 4 0.0009
126 EXOPHTHALMOS 2 0.0009
127 VULVOVAGINAL DRYNESS 3 0.0009
128 BINGE EATING 1 0.0009
129 VITREOUS DETACHMENT 2 0.0009
130 APPLICATION SITE URTICARIA 2 0.0009
131 BENIGN NEOPLASM 1 0.0009
132 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
133 ORAL PRURITUS 2 0.0009
134 APPLICATION SITE DISCHARGE 1 0.0009
135 APHTHOUS STOMATITIS 2 0.0009
136 FIBROMYALGIA 21 0.0009
137 NECK SURGERY 2 0.0009
138 MENOPAUSAL SYMPTOMS 2 0.0009
139 BLADDER OPERATION 1 0.0009
140 CONTRAST MEDIA REACTION 2 0.0008
141 CARDIAC TAMPONADE 4 0.0008
142 WRONG DOSE 2 0.0008
143 SLOW SPEECH 2 0.0008
144 MALIGNANT MELANOMA 11 0.0008
145 INSTILLATION SITE PAIN 2 0.0008
146 BLADDER DISCOMFORT 1 0.0008
147 SPINAL OSTEOARTHRITIS 7 0.0008
148 VULVOVAGINAL PRURITUS 4 0.0008
149 EXCORIATION 2 0.0008
150 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
151 MENOPAUSE 2 0.0008
152 CONCUSSION 6 0.0008
153 LIPOMA 2 0.0008
154 ABDOMINAL OPERATION 1 0.0008
155 APPLICATION SITE PARAESTHESIA 1 0.0008
156 NAIL DISCOLOURATION 3 0.0008
157 YAWNING 2 0.0007
158 BURSITIS 9 0.0007
159 SPINAL FUSION SURGERY 3 0.0007
160 EAR CONGESTION 2 0.0007
161 RHINALGIA 2 0.0007
162 INTESTINAL ISCHAEMIA 4 0.0007
163 APPLICATION SITE INFLAMMATION 1 0.0007
164 TRICHORRHEXIS 2 0.0007
165 LIGAMENT SPRAIN 7 0.0007
166 ABORTION 2 0.0007
167 STRABISMUS 2 0.0007
168 ANKLE OPERATION 1 0.0007
169 CREPITATIONS 2 0.0007
170 ATYPICAL PNEUMONIA 2 0.0007
171 ADHESION 1 0.0007
172 URINE ABNORMALITY 3 0.0007
173 NOCTURIA 8 0.0007
174 SYNOVIAL CYST 3 0.0006
175 DRUG EFFECT INCREASED 2 0.0006
176 ENDOMETRIOSIS 3 0.0006
177 VULVOVAGINAL PAIN 3 0.0006
178 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
179 LOOSE TOOTH 2 0.0006
180 MUSCLE DISORDER 5 0.0006
181 POLYP 4 0.0006
182 SOMNAMBULISM 4 0.0006
183 APPLICATION SITE BURN 3 0.0006
184 SPINAL COMPRESSION FRACTURE 5 0.0006
185 PEPTIC ULCER 2 0.0006
186 ANTIBODY TEST POSITIVE 1 0.0006
187 PROTEIN URINE PRESENT 3 0.0006
188 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
189 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
190 ANXIETY DISORDER 2 0.0006
191 PLANTAR FASCIITIS 2 0.0006
192 PATHOLOGICAL FRACTURE 3 0.0006
193 ABNORMAL LOSS OF WEIGHT 4 0.0006
194 VITAMIN D DECREASED 5 0.0006
195 BRONCHOPNEUMONIA 2 0.0006
196 DIFFICULTY IN WALKING 2 0.0006
197 LEFT VENTRICULAR FAILURE 2 0.0006
198 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
199 ACUTE SINUSITIS 1 0.0006
200 CARDIAC MURMUR 5 0.0006
201 TACHYPHRENIA 2 0.0006
202 ADRENAL INSUFFICIENCY 7 0.0006
203 EXTRASYSTOLES 4 0.0006
204 CARPAL TUNNEL SYNDROME 8 0.0006
205 NECROTISING FASCIITIS 2 0.0006
206 FOOD POISONING 3 0.0006
207 COMPRESSION FRACTURE 3 0.0006
208 APPLICATION SITE DISCOMFORT 1 0.0006
209 BRUXISM 3 0.0006
210 BONE LESION 2 0.0006
211 CHEILITIS 3 0.0006
212 FAECES SOFT 4 0.0005
213 CHOKING SENSATION 3 0.0005
214 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
215 BLADDER SPASM 1 0.0005
216 CHRONIC SINUSITIS 2 0.0005
217 AUTOIMMUNE THYROIDITIS 2 0.0005
218 PARANASAL SINUS DISCOMFORT 2 0.0005
219 PERONEAL NERVE PALSY 3 0.0005
220 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
221 ADRENAL DISORDER 1 0.0005
222 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
223 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
224 ERECTILE DYSFUNCTION 13 0.0005
225 NASAL DISCOMFORT 4 0.0005
226 GASTROENTERITIS VIRAL 9 0.0005
227 FUNGAL SKIN INFECTION 2 0.0005
228 VAGINAL DISCHARGE 5 0.0005
229 HOMICIDAL IDEATION 2 0.0005
230 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
231 TRIGGER FINGER 2 0.0005
232 APPLICATION SITE EXFOLIATION 2 0.0005
233 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
234 INFUSION SITE EXTRAVASATION 3 0.0005
235 GASTROENTERITIS 7 0.0005
236 CYSTITIS 15 0.0005
237 CARDIAC FAILURE CHRONIC 2 0.0005
238 MUSCULOSKELETAL DISCOMFORT 8 0.0005
239 HYSTERECTOMY 4 0.0005
240 BRADYPHRENIA 3 0.0005
241 ONYCHOMYCOSIS 2 0.0005
242 ACCIDENT AT WORK 1 0.0005
243 SKIN INFECTION 5 0.0004
244 HYPOTHYROIDISM 14 0.0004
245 PERIPHERAL COLDNESS 6 0.0004
246 DISEASE COMPLICATION 2 0.0004
247 LUMBAR VERTEBRAL FRACTURE 2 0.0004
248 INCREASED TENDENCY TO BRUISE 4 0.0004
249 HAIR GROWTH ABNORMAL 3 0.0004
250 NERVE COMPRESSION 4 0.0004
251 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
252 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
253 HUNGER 6 0.0004
254 FEELING OF DESPAIR 2 0.0004
255 TIBIA FRACTURE 2 0.0004
256 VAGINAL INFECTION 2 0.0004
257 SEASONAL ALLERGY 6 0.0004
258 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
259 POOR QUALITY SLEEP 9 0.0004
260 TONGUE DISORDER 3 0.0004
261 MENTAL IMPAIRMENT 10 0.0004
262 VITAMIN D DEFICIENCY 4 0.0004
263 ORAL DISORDER 3 0.0004
264 VITREOUS FLOATERS 4 0.0004
265 SPRUE-LIKE ENTEROPATHY 2 0.0004
266 STAPHYLOCOCCAL SEPSIS 2 0.0004
267 ARTHROPOD BITE 3 0.0004
268 EXPIRED DRUG ADMINISTERED 2 0.0004
269 APPLICATION SITE SWELLING 2 0.0004
270 HEPATIC ENZYME ABNORMAL 2 0.0004
271 GENERAL SYMPTOM 3 0.0004
272 BRAIN INJURY 4 0.0004
273 BREAST TENDERNESS 3 0.0004
274 SLUGGISHNESS 4 0.0004
275 EAR DISCOMFORT 4 0.0004
276 PERIPHERAL VASCULAR DISORDER 2 0.0004
277 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
278 TRISMUS 2 0.0004
279 VARICOSE VEIN 2 0.0004
280 STOMACH DISCOMFORT 2 0.0004
281 APHTHOUS ULCER 3 0.0004
282 PELVIC PAIN 7 0.0004
283 ACTINIC KERATOSIS 1 0.0004
284 PERIORBITAL OEDEMA 2 0.0004
285 RESTLESS LEGS SYNDROME 7 0.0004
286 MULTIPLE ALLERGIES 3 0.0004
287 WEIGHT FLUCTUATION 4 0.0004
288 PARTIAL SEIZURES 2 0.0004
289 ORAL CANDIDIASIS 5 0.0004
290 BLOOD LACTIC ACID INCREASED 2 0.0004
291 POLYARTHRITIS 2 0.0004
292 RENAL CYST 3 0.0004
293 RENAL PAIN 4 0.0004
294 ANIMAL BITE 1 0.0004
295 BODY HEIGHT DECREASED 4 0.0004
296 ANAESTHETIC COMPLICATION 1 0.0004
297 OVERWEIGHT 2 0.0004
298 STENT PLACEMENT 3 0.0004
299 STRESS FRACTURE 2 0.0004
300 HIP SURGERY 2 0.0004
301 ERYTHEMA OF EYELID 2 0.0004
302 BACK DISORDER 6 0.0004
303 ANORGASMIA 1 0.0004
304 ABNORMAL FAECES 3 0.0004
305 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
306 ASTHENOPIA 2 0.0004
307 PROSTATIC DISORDER 2 0.0004
308 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
309 FOOT DEFORMITY 4 0.0004
310 TOOTH DISORDER 8 0.0004
311 ORAL PAIN 8 0.0004
312 UNEVALUABLE EVENT 27 0.0004
313 INFUSION SITE ERYTHEMA 3 0.0004
314 EYE INFECTION 4 0.0004
315 OSTEOARTHRITIS 15 0.0004
316 SINUS DISORDER 7 0.0004
317 METRORRHAGIA 6 0.0004
318 SCAR 6 0.0004
319 PARANOIA 6 0.0003
320 EXERCISE TOLERANCE DECREASED 2 0.0003
321 MUSCLE STRAIN 3 0.0003
322 ELECTROLYTE IMBALANCE 4 0.0003
323 SKIN WARM 2 0.0003
324 NIGHT SWEATS 11 0.0003
325 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
326 URINE ODOUR ABNORMAL 2 0.0003
327 IMMUNOSUPPRESSION 3 0.0003
328 LUNG INFILTRATION 3 0.0003
329 DECREASED INTEREST 2 0.0003
330 DEPRESSION 77 0.0003
331 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
332 BRONCHITIS 25 0.0003
333 CELLULITIS 17 0.0003
334 PLEURISY 2 0.0003
335 SINUS HEADACHE 2 0.0003
336 SYMPTOM RECURRENCE 2 0.0003
337 FEELING ABNORMAL 80 0.0003
338 WRIST FRACTURE 4 0.0003
339 LOSS OF LIBIDO 3 0.0003
340 ANAL INCONTINENCE 3 0.0003
341 APHASIA 10 0.0003
342 LUPUS-LIKE SYNDROME 3 0.0003
343 VIRAL INFECTION 11 0.0003
344 FUNGAL INFECTION 11 0.0003
345 NO THERAPEUTIC RESPONSE 4 0.0003
346 JOINT INJURY 7 0.0003
347 MUSCLE SPASTICITY 4 0.0003
348 MENISCUS INJURY 2 0.0003
349 UROSEPSIS 3 0.0003
350 DIVERTICULITIS 9 0.0003
351 SPINAL OPERATION 4 0.0003
352 INJECTION SITE EXTRAVASATION 4 0.0003
353 TENDON RUPTURE 4 0.0003
354 DRUG DIVERSION 2 0.0003
355 ANKLE FRACTURE 5 0.0003
356 TENDONITIS 5 0.0003
357 INSOMNIA 86 0.0003
358 NECK PAIN 18 0.0003
359 BACTERIAL INFECTION 6 0.0003
360 APPLICATION SITE IRRITATION 4 0.0003
361 COGNITIVE DISORDER 15 0.0003
362 DRY EYE 16 0.0003
363 GASTRIC DISORDER 11 0.0003
364 FLANK PAIN 3 0.0003
365 BLOOD BLISTER 1 0.0003
366 PHOTOPSIA 2 0.0003
367 RESPIRATORY TRACT CONGESTION 5 0.0003
368 SCREAMING 2 0.0003
369 SCIATICA 5 0.0003
370 SINUSITIS 32 0.0003
371 POLLAKIURIA 13 0.0003
372 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
373 RASH GENERALISED 8 0.0003
374 INJECTION SITE INDURATION 4 0.0003
375 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
376 AUTOIMMUNE DISORDER 3 0.0003
377 AMNESIA 20 0.0003
378 BACTERIAL SEPSIS 1 0.0003
379 PLATELET COUNT INCREASED 4 0.0003
380 HEPATOMEGALY 3 0.0003
381 BEDRIDDEN 4 0.0003
382 MIGRAINE 29 0.0003
383 TOOTH INFECTION 4 0.0003
384 PRODUCT FORMULATION ISSUE 2 0.0003
385 CRYING 11 0.0003
386 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
387 BREAST MASS 2 0.0003
388 CANDIDA INFECTION 5 0.0003
389 PRODUCT LABEL ISSUE 2 0.0003
390 TOOTH ABSCESS 3 0.0003
391 NEUTROPHIL COUNT INCREASED 3 0.0003
392 CROHN'S DISEASE 2 0.0003
393 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
394 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
395 LYMPHOEDEMA 2 0.0003
396 TENDERNESS 3 0.0003
397 LOCAL SWELLING 5 0.0003
398 APHONIA 4 0.0003
399 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
400 INCONTINENCE 3 0.0003
401 NEPHROLITHIASIS 13 0.0003
402 DIVERTICULUM 2 0.0003
403 APPENDICECTOMY 1 0.0003
404 THIRST 5 0.0003
405 LIVER FUNCTION TEST INCREASED 6 0.0003
406 CARDIOGENIC SHOCK 4 0.0003
407 APPARENT DEATH 1 0.0003
408 BALANCE DISORDER 24 0.0003
409 PANIC REACTION 2 0.0003
410 ANOSMIA 4 0.0003
411 SKIN LACERATION 3 0.0003
412 BLOOD PRESSURE INCREASED 42 0.0003
413 WOUND INFECTION 3 0.0003
414 HYPOPHAGIA 7 0.0003
415 MAJOR DEPRESSION 2 0.0003
416 UTERINE LEIOMYOMA 2 0.0003
417 TOOTH FRACTURE 3 0.0003
418 NERVE INJURY 3 0.0003
419 FEELING DRUNK 2 0.0003
420 SUNBURN 2 0.0003
421 SOMNOLENCE 54 0.0003
422 THROAT IRRITATION 12 0.0003
423 MUSCULOSKELETAL PAIN 14 0.0003
424 HEART RATE IRREGULAR 6 0.0003
425 HOT FLUSH 20 0.0003
426 BLOOD SODIUM DECREASED 5 0.0003
427 APPLICATION SITE PRURITUS 6 0.0003
428 MOBILITY DECREASED 19 0.0003
429 TENDON PAIN 2 0.0003
430 IMPAIRED DRIVING ABILITY 3 0.0003
431 OSTEOPENIA 4 0.0003
432 CHOLECYSTECTOMY 3 0.0003
433 SUICIDAL IDEATION 24 0.0003
434 ACIDOSIS 2 0.0003
435 DRUG PRESCRIBING ERROR 5 0.0003
436 GLAUCOMA 5 0.0003
437 ATRIOVENTRICULAR BLOCK 2 0.0003
438 EYELID OEDEMA 3 0.0003
439 RENAL DISORDER 12 0.0003
440 BLOOD CHOLESTEROL INCREASED 12 0.0003
441 FLUID RETENTION 13 0.0003
442 ABNORMAL DREAMS 7 0.0003
443 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
444 FURUNCLE 2 0.0003
445 HAEMATOCRIT DECREASED 5 0.0003
446 HYPERLIPIDAEMIA 3 0.0003
447 WOUND 7 0.0003
448 BLOOD DISORDER 2 0.0002
449 LOCALISED INFECTION 6 0.0002
450 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
451 MUSCLE TIGHTNESS 4 0.0002
452 FEEDING DISORDER 5 0.0002
453 APPLICATION SITE DISCOLOURATION 1 0.0002
454 POST PROCEDURAL INFECTION 2 0.0002
455 MUSCLE SPASMS 45 0.0002
456 BODY TEMPERATURE INCREASED 5 0.0002
457 HYPERSOMNIA 7 0.0002
458 DYSPEPSIA 24 0.0002
459 SMALL INTESTINAL OBSTRUCTION 3 0.0002
460 IMPAIRED HEALING 8 0.0002
461 HYPERAESTHESIA 2 0.0002
462 EYE DISORDER 8 0.0002
463 ESCHERICHIA INFECTION 2 0.0002
464 OSTEOPOROSIS 10 0.0002
465 ANAPHYLACTOID REACTION 1 0.0002
466 INFLUENZA LIKE ILLNESS 20 0.0002
467 ABASIA 6 0.0002
468 HEART RATE INCREASED 24 0.0002
469 PARAESTHESIA 38 0.0002
470 MUSCLE INJURY 2 0.0002
471 DYSPHONIA 14 0.0002
472 SENSATION OF FOREIGN BODY 2 0.0002
473 MUSCLE ATROPHY 3 0.0002
474 ANAPHYLACTIC REACTION 13 0.0002
475 RETCHING 5 0.0002
476 IMPAIRED WORK ABILITY 5 0.0002
477 HYPERHIDROSIS 30 0.0002
478 INFUSION SITE PAIN 3 0.0002
479 BLOOD POTASSIUM DECREASED 7 0.0002
480 ABNORMAL SENSATION IN EYE 1 0.0002
481 MULTI-ORGAN FAILURE 4 0.0002
482 DIPLOPIA 6 0.0002
483 RESPIRATORY TRACT INFECTION 6 0.0002
484 ORTHOSTATIC HYPOTENSION 4 0.0002
485 VERTIGO 14 0.0002
486 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
487 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
488 URINE OUTPUT DECREASED 2 0.0002
489 ANXIETY 65 0.0002
490 DRUG ADMINISTRATION ERROR 7 0.0002
491 BLOOD CALCIUM INCREASED 2 0.0002
492 PULMONARY CONGESTION 3 0.0002
493 COLD SWEAT 4 0.0002
494 LYMPHOCYTE COUNT DECREASED 4 0.0002
495 DYSMENORRHOEA 3 0.0002
496 LIMB DISCOMFORT 7 0.0002
497 HEAD DISCOMFORT 4 0.0002
498 HEADACHE 140 0.0002
499 GOUT 4 0.0002
500 THROAT TIGHTNESS 6 0.0002
501 FATIGUE 172 0.0002
502 NEUROPATHY PERIPHERAL 21 0.0002
503 IMPAIRED GASTRIC EMPTYING 3 0.0002
504 MUSCULAR WEAKNESS 25 0.0002
505 PANIC ATTACK 8 0.0002
506 BRAIN NEOPLASM 2 0.0002
507 RETINAL DETACHMENT 2 0.0002
508 DYSURIA 8 0.0002
509 URINARY TRACT INFECTION 37 0.0002
510 ARTHRITIS 17 0.0002
511 ARTHRITIS INFECTIVE 1 0.0002
512 THINKING ABNORMAL 4 0.0002
513 MIDDLE INSOMNIA 4 0.0002
514 APPENDICITIS 2 0.0002
515 LACERATION 2 0.0002
516 STAPHYLOCOCCAL INFECTION 7 0.0002
517 FOOT FRACTURE 4 0.0002
518 CONSTIPATION 46 0.0002
519 SPEECH DISORDER 11 0.0002
520 DEHYDRATION 28 0.0002
521 FEELING JITTERY 4 0.0002
522 RECALLED PRODUCT ADMINISTERED 2 0.0002
523 EYE INFLAMMATION 2 0.0002
524 DRY MOUTH 17 0.0002
525 HERPES ZOSTER 12 0.0002
526 PRODUCT SUBSTITUTION ISSUE 12 0.0002
527 PRESCRIBED OVERDOSE 4 0.0002
528 BACK PAIN 48 0.0002
529 DYSSTASIA 6 0.0002
530 CHILLS 24 0.0002
531 PHARYNGEAL SWELLING 2 0.0002
532 DISTURBANCE IN ATTENTION 11 0.0002
533 COELIAC DISEASE 2 0.0002
534 KIDNEY INFECTION 4 0.0002
535 MENORRHAGIA 4 0.0002
536 KNEE OPERATION 2 0.0002
537 SKIN HAEMORRHAGE 3 0.0002
538 BLADDER DISORDER 2 0.0002
539 ABDOMINAL TENDERNESS 1 0.0002
540 WEIGHT INCREASED 45 0.0002
541 GASTROINTESTINAL DISORDER 18 0.0002
542 ANEURYSM 1 0.0002
543 UPPER LIMB FRACTURE 4 0.0002
544 WEIGHT DECREASED 56 0.0002
545 AGEUSIA 5 0.0002
546 SPINAL FRACTURE 4 0.0002
547 PRODUCT PHYSICAL ISSUE 4 0.0002
548 ASTHENIA 74 0.0002
549 INFUSION RELATED REACTION 13 0.0002
550 EUPHORIC MOOD 2 0.0002
551 RIB FRACTURE 4 0.0002
552 OROPHARYNGEAL PAIN 18 0.0002
553 MYALGIA 33 0.0002
554 MUSCULOSKELETAL STIFFNESS 17 0.0002
555 MUSCULOSKELETAL CHEST PAIN 3 0.0002
556 RHEUMATOID ARTHRITIS 22 0.0002
557 SKIN ULCER 5 0.0002
558 EYE DISCHARGE 2 0.0002
559 ARTHRALGIA 80 0.0002
560 CONVULSION 11 0.0002
561 ROAD TRAFFIC ACCIDENT 8 0.0002
562 TRANSFUSION 2 0.0002
563 HEPATIC ENZYME INCREASED 13 0.0002
564 KNEE ARTHROPLASTY 4 0.0002
565 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
566 MEMORY IMPAIRMENT 26 0.0002
567 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
568 ULCER 3 0.0002
569 INFLUENZA 21 0.0002
570 OBESITY 3 0.0002
571 ANORECTAL DISCOMFORT 1 0.0002
572 EAR INFECTION 5 0.0002
573 PALPITATIONS 22 0.0002
574 BREAST PAIN 2 0.0002
575 HYPOAESTHESIA 28 0.0002
576 CONTUSION 18 0.0002
577 FLUSHING 19 0.0002
578 IRRITABLE BOWEL SYNDROME 4 0.0002
579 DIZZINESS 93 0.0002
580 HEREDITARY ANGIOEDEMA 2 0.0002
581 HYPOGLYCAEMIA 9 0.0002
582 DECREASED ACTIVITY 2 0.0002
583 BURNING SENSATION 13 0.0002
584 ABDOMINAL DISCOMFORT 31 0.0002
585 ACNE 14 0.0002
586 VAGINAL HAEMORRHAGE 8 0.0002
587 SLEEP DISORDER 13 0.0002
588 LIMB INJURY 5 0.0002
589 BACK INJURY 2 0.0002
590 MENTAL DISORDER 8 0.0002
591 PULMONARY THROMBOSIS 2 0.0002
592 PAIN IN EXTREMITY 54 0.0002
593 NAUSEA 145 0.0002
594 IRRITABILITY 11 0.0002
595 BLOOD GLUCOSE FLUCTUATION 2 0.0002
596 PHOTOSENSITIVITY REACTION 3 0.0002
597 SWELLING 17 0.0002
598 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
599 PROCEDURAL PAIN 5 0.0002
600 ARTHROPATHY 10 0.0002
601 URINARY RETENTION 6 0.0002
602 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
603 GAIT INABILITY 6 0.0002
604 FEELING HOT 11 0.0002
605 PLASMA CELL MYELOMA 7 0.0002
606 HYPERTENSION 38 0.0002
607 ANGIOPATHY 1 0.0002
608 SNEEZING 4 0.0002
609 ALOPECIA 35 0.0002
610 OCULAR DISCOMFORT 2 0.0002
611 ANGER 6 0.0002
612 CHROMATURIA 4 0.0002
613 HEMIPARESIS 3 0.0002
614 ABNORMAL BEHAVIOUR 7 0.0002
615 PAIN IN JAW 5 0.0002
616 SCAB 2 0.0002
617 PERIPHERAL SWELLING 27 0.0002
618 INJECTION SITE REACTION 12 0.0002
619 NIGHTMARE 6 0.0002
620 ABDOMINAL DISTENSION 18 0.0002
621 NERVOUSNESS 9 0.0002
622 SPLENOMEGALY 2 0.0002
623 BONE PAIN 10 0.0002
624 SEXUAL DYSFUNCTION 2 0.0002
625 SURGERY 10 0.0002
626 NASAL CONGESTION 10 0.0002
627 ACUTE MYOCARDIAL INFARCTION 5 0.0002
628 COVID-19 PNEUMONIA 2 0.0002
629 MALAISE 74 0.0002
630 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
631 BACTERAEMIA 2 0.0002
632 ATAXIA 2 0.0002
633 GALLBLADDER DISORDER 3 0.0002
634 PRODUCT ADHESION ISSUE 6 0.0002
635 PRODUCTIVE COUGH 8 0.0002
636 JOINT SWELLING 20 0.0002
637 STOMATITIS 10 0.0002
638 BONE DISORDER 3 0.0002
639 NEURALGIA 4 0.0002
640 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
641 INJECTION SITE URTICARIA 4 0.0002
642 TREMOR 27 0.0002
643 HYPOACUSIS 7 0.0002
644 ABNORMAL WEIGHT GAIN 2 0.0002
645 OSTEONECROSIS OF JAW 4 0.0002
646 DYSGEUSIA 12 0.0002
647 CYST 2 0.0002
648 TOOTH EXTRACTION 2 0.0002
649 INJECTION SITE DISCOLOURATION 2 0.0002
650 PEMPHIGUS 2 0.0002
651 SECRETION DISCHARGE 2 0.0002
652 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
653 BLOOD URINE PRESENT 3 0.0002
654 GASTRIC ULCER 3 0.0002
655 PROTEINURIA 3 0.0002
656 INJECTION SITE IRRITATION 2 0.0002
657 MOOD SWINGS 5 0.0002
658 HEPATITIS 4 0.0002
659 POST PROCEDURAL COMPLICATION 3 0.0002
660 PRURITUS 60 0.0002
661 ACUTE RESPIRATORY FAILURE 3 0.0002
662 OEDEMA PERIPHERAL 19 0.0002
663 ANOREXIA 2 0.0002
664 HERNIA 3 0.0002
665 ERUCTATION 3 0.0002
666 RHINORRHOEA 10 0.0002
667 HIATUS HERNIA 2 0.0002
668 APPLICATION SITE VESICLES 1 0.0002
669 ANGINA UNSTABLE 1 0.0002
670 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
671 HAEMORRHOIDS 3 0.0002
672 SWELLING FACE 10 0.0002
673 PRODUCT DOSE OMISSION 10 0.0002
674 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
675 TINNITUS 7 0.0002
676 INFECTION 22 0.0002
677 DIARRHOEA 98 0.0002
678 DISABILITY 3 0.0002
679 ADVERSE REACTION 2 0.0002
680 FALL 50 0.0002
681 COUGH 42 0.0001
682 HAIR TEXTURE ABNORMAL 2 0.0001
683 MENSTRUATION IRREGULAR 4 0.0001
684 QUALITY OF LIFE DECREASED 2 0.0001
685 FEAR 4 0.0001
686 PAIN OF SKIN 4 0.0001
687 THERAPEUTIC RESPONSE DECREASED 9 0.0001
688 OEDEMA 8 0.0001
689 MOOD ALTERED 4 0.0001
690 CHEST DISCOMFORT 15 0.0001
691 GINGIVAL BLEEDING 2 0.0001
692 CORONARY ARTERY OCCLUSION 2 0.0001
693 SKIN LESION 4 0.0001
694 VISION BLURRED 20 0.0001
695 APPLICATION SITE RASH 2 0.0001
696 DIABETES MELLITUS 11 0.0001
697 ORAL DISCOMFORT 2 0.0001
698 FEELING COLD 4 0.0001
699 HYPOMAGNESAEMIA 2 0.0001
700 COORDINATION ABNORMAL 2 0.0001
701 DERMATITIS 3 0.0001
702 RASH 62 0.0001
703 BLINDNESS UNILATERAL 2 0.0001
704 EYE PAIN 8 0.0001
705 LYMPHADENOPATHY 5 0.0001
706 SINUS TACHYCARDIA 2 0.0001
707 PRODUCT QUALITY ISSUE 19 0.0001
708 LETHARGY 8 0.0001
709 PRURITUS GENERALISED 3 0.0001
710 PARAESTHESIA ORAL 2 0.0001
711 HYPERTHYROIDISM 2 0.0001
712 CONDITION AGGRAVATED 42 0.0001
713 HYPOKINESIA 2 0.0001
714 DRUG EFFECT INCOMPLETE 5 0.0001
715 APATHY 2 0.0001
716 INTENTIONAL PRODUCT MISUSE 12 0.0001
717 CARDIOMYOPATHY 2 0.0001
718 INJECTION SITE MASS 5 0.0001
719 URINARY INCONTINENCE 4 0.0001
720 CATARACT 8 0.0001
721 PULMONARY MASS 2 0.0001
722 COLITIS ULCERATIVE 6 0.0001
723 GLOSSODYNIA 3 0.0001
724 RESPIRATORY DISORDER 4 0.0001
725 ATRIAL FIBRILLATION 13 0.0001
726 PANCREATITIS ACUTE 3 0.0001
727 PANCREATITIS 7 0.0001
728 DEPRESSED MOOD 7 0.0001
729 BLOOD COUNT ABNORMAL 2 0.0001
730 PAIN 81 0.0001
731 AORTIC ANEURYSM 1 0.0001
732 SKIN DISCOLOURATION 6 0.0001
733 INJECTION SITE RASH 4 0.0001
734 PHARYNGEAL OEDEMA 2 0.0001
735 DRUG EFFECT DECREASED 7 0.0001
736 SYNCOPE 13 0.0001
737 BASAL CELL CARCINOMA 2 0.0001
738 NERVOUS SYSTEM DISORDER 4 0.0001
739 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
740 AFFECTIVE DISORDER 1 0.0001
741 PRODUCT USE COMPLAINT 2 0.0001
742 ABDOMINAL PAIN UPPER 26 0.0001
743 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
744 DISORIENTATION 5 0.0001
745 PNEUMOTHORAX 2 0.0001
746 VOMITING 59 0.0001
747 ABSCESS 2 0.0001
748 ATRIAL FLUTTER 1 0.0001
749 BLOOD PRESSURE FLUCTUATION 3 0.0001
750 ABORTION SPONTANEOUS 5 0.0001
751 BLISTER 7 0.0001
752 CARDIAC FAILURE CONGESTIVE 10 0.0001
753 CONFUSIONAL STATE 20 0.0001
754 FLATULENCE 7 0.0001
755 PSORIATIC ARTHROPATHY 5 0.0001
756 DEEP VEIN THROMBOSIS 8 0.0001
757 DEVICE ISSUE 11 0.0001
758 VISUAL IMPAIRMENT 15 0.0001
759 BLOOD PRESSURE DECREASED 8 0.0001
760 ABDOMINAL PAIN 28 0.0001
761 EXPIRED PRODUCT ADMINISTERED 4 0.0001
762 LIP SWELLING 4 0.0001
763 COAGULOPATHY 2 0.0001
764 BLOOD UREA INCREASED 2 0.0001
765 ATRIAL SEPTAL DEFECT 1 0.0001
766 URTICARIA 20 0.0001
767 NASOPHARYNGITIS 22 0.0001
768 EYE PRURITUS 4 0.0001
769 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
770 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
771 HYPERSENSITIVITY 22 0.0001
772 INJECTION SITE SWELLING 9 0.0001
773 LOSS OF CONSCIOUSNESS 15 0.0001
774 HAEMATURIA 4 0.0001
775 ERYTHEMA 24 0.0001
776 SEPSIS 13 0.0001
777 INFLAMMATION 6 0.0001
778 UNRESPONSIVE TO STIMULI 3 0.0001
779 ASTHMA 13 0.0001
780 SEDATION 3 0.0001
781 APPLICATION SITE ERYTHEMA 3 0.0001
782 DEVICE USE ISSUE 2 0.0001
783 GASTRITIS 3 0.0001
784 DRUG WITHDRAWAL SYNDROME 10 0.0001
785 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
786 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
787 DRUG ERUPTION 2 0.0001
788 EXPOSURE DURING PREGNANCY 7 0.0001
789 TACHYCARDIA 10 0.0001
790 SEIZURE 13 0.0001
791 ISCHAEMIC STROKE 2 0.0001
792 SYNOVITIS 2 0.0001
793 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
794 TOOTHACHE 2 0.0001
795 HYPERGLYCAEMIA 4 0.0001
796 GAIT DISTURBANCE 21 0.0001
797 END STAGE RENAL DISEASE 2 0.0001
798 AGITATION 8 0.0001
799 PNEUMONIA 35 0.0001
800 CONJUNCTIVITIS 2 0.0001
801 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
802 EYE SWELLING 4 0.0001
803 PYREXIA 37 0.0001
804 CARDIAC DISORDER 10 0.0001
805 DYSARTHRIA 4 0.0001
806 ARTERIOSCLEROSIS 1 0.0001
807 FRACTURE 2 0.0001
808 INCORRECT DOSE ADMINISTERED 24 0.0001
809 MUSCULOSKELETAL DISORDER 2 0.0001
810 INJECTION SITE ERYTHEMA 13 0.0001
811 INJECTION SITE PRURITUS 7 0.0001
812 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
813 DYSPNOEA 59 0.0001
814 AFFECT LABILITY 1 0.0001
815 DECREASED APPETITE 24 0.0001
816 EAR PAIN 2 0.0001
817 CHEST PAIN 19 0.0001
818 ORAL HERPES 2 0.0001
819 PSYCHOTIC DISORDER 3 0.0001
820 BLOOD PRESSURE ABNORMAL 2 0.0001
821 CEREBROVASCULAR ACCIDENT 17 0.0001
822 INJECTION SITE HAEMORRHAGE 8 0.0001
823 AGGRESSION 5 0.0001
824 PREGNANCY 2 0.0001
825 CORONARY ARTERY DISEASE 3 0.0001
826 PRODUCT ADMINISTRATION ERROR 2 0.0001
827 ILL-DEFINED DISORDER 6 0.0001
828 EXTRA DOSE ADMINISTERED 4 0.0001
829 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
830 INJURY ASSOCIATED WITH DEVICE 2 0.0001
831 BLINDNESS 4 0.0001
832 THERAPY CESSATION 5 0.0001
833 PRODUCT PREPARATION ERROR 2 0.0001
834 EMOTIONAL DISORDER 3 0.0001
835 GYNAECOMASTIA 3 0.0001
836 DRUG DOSE OMISSION 16 0.0001
837 PULMONARY HYPERTENSION 2 0.0001
838 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
839 PRODUCT USE ISSUE 18 0.0001
840 ECZEMA 5 0.0001
841 WITHDRAWAL SYNDROME 4 0.0001
842 SKIN EXFOLIATION 8 0.0001
843 DYSPHAGIA 9 0.0001
844 HEAD INJURY 3 0.0001
845 HYPOTENSION 19 0.0001
846 PULMONARY EMBOLISM 9 0.0001
847 INJECTION SITE PAIN 29 0.0001
848 RENAL FAILURE ACUTE 4 0.0001
849 EATING DISORDER 2 0.0001
850 EPISTAXIS 7 0.0001
851 HIP FRACTURE 3 0.0001
852 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
853 BIPOLAR DISORDER 1 0.0001
854 MYOCARDIAL INFARCTION 16 0.0001
855 TREATMENT NONCOMPLIANCE 5 0.0001
856 OSTEONECROSIS 3 0.0001
857 ASPIRATION 1 0.0001
858 VISUAL ACUITY REDUCED 3 0.0001
859 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
860 BLOOD GLUCOSE INCREASED 17 0.0001
861 SKIN DISORDER 3 0.0001
862 RASH PAPULAR 2 0.0001
863 ANAEMIA 17 0.0001
864 TYPE 2 DIABETES MELLITUS 3 0.0001
865 BLOOD CALCIUM DECREASED 1 0.0001
866 DRUG INTERACTION 14 0.0001
867 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
868 INJECTION SITE BRUISING 7 0.0001
869 HAEMOGLOBIN DECREASED 9 0.0001
870 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
871 SKIN IRRITATION 4 0.0001
872 THROMBOSIS 7 0.0001
873 MUSCLE TWITCHING 2 0.0001
874 HYPOKALAEMIA 4 0.0001
875 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
876 HEART RATE DECREASED 3 0.0001
877 DRUG INEFFECTIVE 112 0.0001
878 WHEEZING 5 0.0001
879 OCULAR HYPERAEMIA 4 0.0001
880 PRODUCT PRESCRIBING ERROR 2 0.0001
881 CEREBRAL HAEMORRHAGE 3 0.0001
882 MULTIPLE SCLEROSIS 4 0.0001
883 BLOOD GLUCOSE DECREASED 4 0.0001
884 DIABETIC KETOACIDOSIS 2 0.0001
885 PRESYNCOPE 2 0.0001
886 RESTLESSNESS 3 0.0001
887 DYSPNOEA EXERTIONAL 3 0.0001
888 ABDOMINAL PAIN LOWER 2 0.0001
889 CARDIOVASCULAR DISORDER 2 0.0001
890 HAEMATOMA 2 0.0001
891 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
892 HAEMORRHAGE 8 0.0001
893 DEAFNESS 2 0.0001
894 MUCOSAL INFLAMMATION 2 0.0001
895 JOINT STIFFNESS 2 0.0001
896 COVID-19 13 0.0001
897 RASH PRURITIC 4 0.0001
898 PALLOR 2 0.0001
899 ACUTE HEPATIC FAILURE 1 0.0001
900 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
901 RESPIRATORY DISTRESS 2 0.0001
902 INJURY 5 0.0001
903 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
904 RED BLOOD CELL COUNT DECREASED 2 0.0001
905 RECTAL HAEMORRHAGE 3 0.0001
906 OFF LABEL USE 61 0.0001
907 EYE IRRITATION 4 0.0001
908 DEVICE DISLOCATION 3 0.0001
909 SEPTIC SHOCK 3 0.0001
910 PSORIASIS 9 0.0001
911 NEEDLE ISSUE 2 0.0001
912 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
913 RESPIRATORY FAILURE 5 0.0001
914 UNDERDOSE 5 0.0001
915 RENAL FAILURE 9 0.0001
916 LABORATORY TEST ABNORMAL 2 0.0001
917 DRY SKIN 9 0.0001
918 PULMONARY OEDEMA 3 0.0001
919 THERAPY NON-RESPONDER 3 0.0001
920 HALLUCINATION 5 0.0001
921 NO ADVERSE EVENT 12 0.0001
922 LACRIMATION INCREASED 2 0.0001
923 DISCOMFORT 4 0.0001
924 EPILEPSY 2 0.0001
925 HOSPITALISATION 10 0.0001
926 BONE DENSITY DECREASED 2 0.0001
927 ARRHYTHMIA 3 0.0001
928 COMA 3 0.0001
929 MOVEMENT DISORDER 2 0.0001
930 CHOLELITHIASIS 2 0.0001
931 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
932 NEOPLASM PROGRESSION 2 0.0001
933 RASH MACULAR 2 0.0001
934 AMENORRHOEA 1 0.0001
935 DEVICE MALFUNCTION 4 0.0001
936 HYPOXIA 2 0.0001
937 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
938 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
939 ADVERSE DRUG REACTION 5 0.0001
940 C-REACTIVE PROTEIN INCREASED 2 0.0001
941 ACCIDENTAL OVERDOSE 2 0.0001
942 HAEMATOCHEZIA 3 0.0001
943 INTESTINAL OBSTRUCTION 2 0.0001
944 COLITIS 2 0.0001
945 ACUTE KIDNEY INJURY 8 0.0001
946 DRUG INTOLERANCE 5 0.0001
947 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
948 DYSKINESIA 2 0.0000
949 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
950 APPLICATION SITE PAIN 1 0.0000
951 LIVER DISORDER 2 0.0000
952 BREAST CANCER 4 0.0000
953 DISEASE RECURRENCE 2 0.0000
954 THERAPY INTERRUPTED 3 0.0000
955 SKIN BURNING SENSATION 3 0.0000
956 RASH ERYTHEMATOUS 2 0.0000
957 EMOTIONAL DISTRESS 5 0.0000
958 PRODUCT DOSE OMISSION ISSUE 12 0.0000
959 LEUKOPENIA 2 0.0000
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
961 ILLNESS 4 0.0000
962 ANAPHYLACTIC SHOCK 1 0.0000
963 ANHEDONIA 1 0.0000
964 PLATELET COUNT DECREASED 4 0.0000
965 CARDIAC FAILURE 3 0.0000
966 PROSTATE CANCER 3 0.0000
967 TREATMENT FAILURE 3 0.0000
968 PANCYTOPENIA 2 0.0000
969 HYPONATRAEMIA 2 0.0000
970 ANGINA PECTORIS 1 0.0000
971 PRODUCT STORAGE ERROR 3 0.0000
972 ASCITES 1 0.0000
973 DISEASE PROGRESSION 4 0.0000
974 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
975 PLEURAL EFFUSION 2 0.0000
976 ADVERSE EVENT 3 0.0000
977 BLOOD CREATININE INCREASED 2 0.0000
978 NEUTROPENIA 4 0.0000
979 THROMBOCYTOPENIA 3 0.0000
980 CARDIAC ARREST 2 0.0000
981 DRUG ABUSE 2 0.0000
982 OVERDOSE 5 0.0000
983 DEATH 19 0.0000
984 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
985 DRUG DEPENDENCE 3 0.0000
986 BLADDER CANCER 1 0.0000
987 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
988 TOXICITY TO VARIOUS AGENTS 2 0.0000